Effect of taxol on chromosome aberrations induced by gamma radiation or by doxorubicin in Chinese hamster ovary cells

Brazilian Journal of Genetics

Volumn 20, Issue 3, 1997, Pages 389-395

  Da Luz Dias, Francisca ^a   Antunes, Lusânia M G ^a   Takahashi, Catarina S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; PACLITAXEL;

ANIMAL CELL; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL CYCLE G2 PHASE; CHO CELL; CHROMOSOME ABERRATION; FEMALE; GAMMA RADIATION; NONHUMAN; RADIATION MUTAGENESIS;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0030680197     PISSN: 01008455     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0100-84551997000300006     Document Type: Article

References (43)

1. Aisner, J., Hiponia, D., Conley, B., Jacobs, M., Gray, W. and Belani, C.F. (1995). Combined modalities in the treatment of head and neck cancer. Semin. Oncol. 22: 28-34.
2. Boros, L., Garrow, G.C., Asbury, R.F. and Chang, A.Y. (1995). Phase I study of escalating doses of paclitaxel (Taxol) with fixed doses of Iphosphamide, Carboplatin, and Etoposide. Semin. Oncol. 22: 28-31.
3. Choy, H. and Browne, M.J. (1995). Paclitaxel as a radiation sensitizer in non-small cell lung cancer. Semin. Oncol. 22: 70-74.
4. Choy, H., Rodriguez, F.F., Koester, S., Hilsenbeck, S. and Von Hoff, D.D. (1993). Investigation of taxol as a potential radiation sensitizer. Cancer 71: 3774-3778.
5. Choy, H., Akerley, W., Safran, H., Clark, J., Rege, V., Papa, A., Glantz, M., Puthawala, Y., Soderberg, C. and Leone, L. (1994). Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cells lung cancer. J. Clin. Oncol 12: 2682-2686.
6. Cornelison, T.L., Goldberg, J.M. and Piver, M.S. (1995). Taxol and platinum chemotherapy in the treatment of pancreatic and jejunal carcinoma. J. Surg. Oncol. 59: 204-208.
7. Donaldson, K.L., Goolsby, G.L. and Wahl, A.F. (1994). Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. Int. J. Cancer 57: 847-855.
8. Geard, C.R. and Jones, J.M. (1994). Radiation and taxol effects on synchronized human cervical carcinoma cells. Int. J. Radiat. Oncol. Biol. Phys. 29: 565-569.
9. Geard, C.R., Jones, J.M. and Schiff, P.B. (1993). Taxol and radiation. Monogr. Natl. Cancer Inst. 15: 89-94.
10. Gianni, L., Munzone, E., Capri, G., Villani, F., Spreafico, C., Tarenzi, E., Fulfaro, F., Caraceni, A., Martini, C., Laffranchi, A., Valagussa, P. and Bonadonna, G. (1995). Paclitaxel in metastatic breast cancer: a trial of two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclines. J. Natl. Cancer Inst. 87: 1169-1175.
11. Hahn, S.M., Liebman, J.E., Cook, J., Fisher, J., Goldspiel, B., Vezon, D., Mitchell, J.B. and Kaufman, D. (1993). Taxol in combination with doxorubicin or etoposide. Possible antagonism in vitro. Cancer 72: 2705-2711.
12. Hennequin, C., Giocanti, N. and Favaudon, V. (1996). Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (taxotere) in HeLa and SQ20B cells. Cancer Res. 56: 1842-1850.
13. Holmes, F.A., Walters, R.S., Theriault, R.L., Forman, A.D., Newton, L.K., Raber, M.N., Buzdar, A.U., Frye, D.K. and Hortobagyi, G.N. (1991). Phase II trial of taxol, an active drug in the treatment of breast cancer. J. Natl. Cancer Inst. 83: 1797-1801.
14. Hornback, N.B., Shen, R.N., Sutton, G.P., Shidnia, H. and Kaiser, H.E. (1994). Synergistic cytotoxic and antitumor effects of irradiation and taxol on human HeLa cervix carcinoma and mouse B16 melanoma cells. In Vivo 8: 819-823.
15. Jordan, M.A., Toso, R.J., Thrower, D. and Wilson, L. (1993). Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc. Natl. Acad. Sci. USA 102: 9552-9556.
16. Kusyk, C.J. and Hsu, T.C. (1976). Adriamycin-induced chromosome damage elevated frequencies of isochromatid aberrations in G2 and S phases. Experientia 32: 1513-1514.
17. Liebmann, J., Cook, J.A., Fisher, J., Teague, D. and Mitchell, J.B. (1994). In vitro studies of taxol as a radiation sensitizer in human tumor cells. J. Natl. Cancer Inst. 86: 441-446.
18. Lokeshwar, B.L., Ferrell, S.M. and Block, N.L. (1995). Enhancement of radiation response of prostatic carcinoma by taxol: therapeutic potential for late-stage malignancy. Anticancer Res. 15: 93-98.
19. Long, L.H. and Fairchild, C.R. (1994). Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telophase. Cancer Res. 54: 4355-4361.
20. Lopes, N.M., Adams, E.G., Pitts, T.W. and Bhuyan, B.K. (1993). Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines. Cancer Chemother. Pharmacol. 32: 235-242.
21. Minarik, L. and Hall, E.J. (1994). Taxol in combination with acute and low dose rate radiation. Radiother. Oncol. 32: 114-118.
22. 2 phase of Chinese hamster cells. In: Radiation Carcinogenesis and DNA Alterations (Burns, F.J., Upton, A.C and Silini, G., eds). Plenum Press-NATO ASI Series, New York, pp. 573-582.
23. Moorhead, P.S., Nowell, P.C., Mellman, W.J., Batipps, D.M. and Hungerford, D.A. (1960). Chromosome preparation of leukocytes cultured from human peripheral blood. Exp. Cell Res. 20: 613-616.
24. Natarajan, A.T. and Obe, G. (1986). How do in vivo mammalian assays compare to in vitro assays in their ability to detect mutagens? Mutat. Res. 167: 189-201.
25. O'Shaughnessy, J.A., Fisherman, J.S. and Cowan, K.H. (1994). Combination paclitaxel (taxol) and doxorubicin therapy for metastatic breast cancer. Semin. Oncol. 21: 19-23.
26. Ozols, R.F. (1995). Carboplatin and paclitaxel in ovarian cancer. Semin. Oncol. 22: 78-83.
27. Pestalozzi, B.C., Sotos, G.A., Choyke, P.L., Fisherman, J.S., Cowan, K.H. and O'Shaughnessy, J.A. (1993). Typhlitis resulting from treatment with taxol and doxorubicin in patients with metastatic breast cancer. Cancer 71: 1797-1800.
28. Preston, R.J., Au, W., Bender, M.A., Brewen, J.G., Carrano, A.V., Heddle, J.A., McFee, A.F., Wolff, S. and Wassom J.S. (1981). Mammalian in vivo and in vitro cytogenetic assays: A report of the EPA's Gene-Tox Program. Mutat. Res. 87: 143-188.
29. Rowinsky, E.K., Donehower, R.C., Jones, R.J. and Tucker, R.W. (1988). Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol. Cancer Res. 48: 4093-4100.
30. Rowinsky, E.K., Cazenave, L.A. and Donehower, R.C. (1990). Taxol: a novel investigational antimicrotubule agent. J. Natl. Cancer Inst. 82: 1247-1259.
31. Rowinsky, E.K., Gilbert, M.R., McGuire, W.P., Noe, D.A., Grochow, L.B., Forastiere, A.A., Ettinger, D.S., Lubejko, B.G., Clark, B., Sartorius, S.E., Cornblath, D.R., Hendricks, C.B. and Danehower, R.C. (1991). Sequences of taxol and cisplatin: A phase I and pharmacologic study. J. Clin. Oncol. 9: 1692-1703.
32. Schiff, P.B. and Horwitz, S.B. (1980). Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA 77: 1561-1565.
33. Schiff, P.B., Fant, J. and Horwitz, S.B. (1979). Promotion of microtubule assembly in vitro by taxol. Nature 277: 665-667.
34. Sinclair, W.K. (1968). Cyclic X-ray responses in mammalian cells in vitro. Radiat. Res. 33: 620-643.
35. Sledge Jr., G.W., Robert, N., Sparano, J.A., Cobeligh, M., Goldstein, L.J., Neuberg, D., Rowinsky, E., Baughman, C. and McCaskill-Stevens, W. (1994). Paclitaxel (Taxol)/doxorubicin combinations in advanced breast cancer: the Eastern Cooperative Oncology Group experience. Semin. Oncol. 21: 15-18.
36. Sledge Jr., G.W., Robert, N., Sparano, J.A., Cogleigh, M., Goldstein, L.J., Neuberg, D., Rowinsky, E., Baughman, C. and McCaskill-Stevens, W. (1995). Eastern Cooperative Oncology Group studies of paclitaxel and doxorubicin in advanced breast cancer. Semin. Oncol. 22: 105-108.
37. Steren, A., Sevin, B.U., Perras, J., Angioli, R., Nguyen, H., Guerra, B.A., Koechli, O. and Averette, H.E. (1993a). Taxol sensitizes human ovarian cancer cells to radiation. Gynecol. Oncol. 48: 252-258.
38. Steren, A., Sevin, B.U., Perras, J., Ramos, R., Angioli, R., Nguyen, H., Koechli, O. and Averette, H.E. (1993b). Taxol as a radiation sensitizer: A flow cytometric study. Gynecol. Oncol. 50: 89-93.
39. Stromberg, J.S., Lee, Y.J., Armour, E.P., Martinez, A.A. and Corry, P.M. (1995). Lack of radiosensitization after paclitaxel treatment of three human carcinoma cell lines. Cancer 75: 2262-2268.
40. Swierenga, S.H.H., Heddle, J.A., Sigal, E.A., Gilman, J.P.W., Brillinger, R.L., Douglas, G.R. and Nestmann, E.R. (1991). Recommended protocols based on a survey of current practice in genotoxicity testing laboratories. IV. Chromosome aberration and sister-chromatid exchange in Chinese hamster ovary, V79 Chinese hamster lung and human lymphocyte cultures. Mutat. Res. 246: 301-322.
41. Tishler, R.B., Geard, C.H., Hall, E.J. and Schiff, P.B. (1992a). Taxol sensitizes human astrocytoma cells to radiation. Cancer Res. 52: 3495-3497.
42. Tishler, R.B., Schiff, P.B., Geard, C.R. and Hall, E.J. (1992b). Taxol: a novel radiation sensitizer. Int. Rad. Oncol. Biol. Phys. 22: 613-617.
43. Vig, B.K. (1971). Chromosome aberrations induced in human leukocytes by the antileukemic antibiotic adriamycin. Cancer Res. 31: 32-37.